Yunnan Baiyao Group Co.,Ltd
000538
Rank in Stocks
#1530
Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd.... Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd. specializes in the pharmaceutical industry. Its diverse portfolio encompasses health supplements, a wide array of medications, medical devices, traditional Chinese medicine ingredients, and even tea. These offerings are marketed under various brand identities, including Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong. The company, established in 1902, maintains its principal offices in Kunming, China.
Share Price
$7.90
Last synced: 2026-10-22
Market Cap
$14.09B
Change (1 day)
-0.13%
Change (1 year)
-0.53%
Country
CN
Trade Yunnan Baiyao Group Co.,Ltd (000538)
Category
Healthcare
P/E ratio for Yunnan Baiyao Group Co.,Ltd (000538)
P/E ratio as of October 2026 TTM: 18.06
According to Yunnan Baiyao Group Co.,Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.06. At the end of 2024 the company had a P/E ratio of 22.54.
P/E ratio history for Yunnan Baiyao Group Co.,Ltd from 2001 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 18.06 | -8.05% |
| 2025 | 19.64 | -12.86% |
| 2024 | 22.54 | 5.01% |
| 2023 | 21.46 | -24.98% |
| 2022 | 28.61 | -39.58% |
| 2021 | 47.35 | 80.08% |
| 2020 | 26.30 | -3.56% |
| 2019 | 27.27 | 3.86% |
| 2018 | 26.25 | -22.65% |
| 2017 | 33.94 | 24.80% |
| 2016 | 27.20 | -0.38% |
| 2015 | 27.30 | 4.18% |
| 2014 | 26.21 | -14.06% |
| 2013 | 30.49 | 2.24% |
| 2012 | 29.82 | -2.10% |
| 2011 | 30.46 | -32.92% |
| 2010 | 45.41 | -14.95% |
| 2009 | 53.39 | 49.01% |
| 2008 | 35.83 | -32.82% |
| 2007 | 53.34 | 19.96% |
| 2006 | 44.46 | 193.47% |
| 2005 | 15.15 | -14.07% |
| 2004 | 17.63 | -33.61% |
| 2003 | 26.56 | -17.64% |
| 2002 | 32.25 | -19.80% |
| 2001 | 40.21 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 23.30 | 29.02% |
DE
|
|
| 26.92 | 49.06% |
DE
|
|
| 55.58 | 207.77% |
JP
|
|
| 61.13 | 238.53% |
CH
|
|
| 34.87 | 93.12% |
IN
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.